Opportunity ID: 350629

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-AG-24-040
Funding Opportunity Title: Microphysiological Systems to Advance Precision Medicine for AD/ADRD Treatment and Prevention (U54 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.866 — Aging Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Oct 19, 2023
Last Updated Date: Oct 19, 2023
Original Closing Date for Applications: Feb 15, 2024
Current Closing Date for Applications: Feb 15, 2024
Archive Date: Mar 22, 2024
Estimated Total Program Funding:
Award Ceiling: $2,500,000
Award Floor:

Eligibility

Eligible Applicants: Native American tribal organizations (other than Federally recognized tribal governments)
City or township governments
Private institutions of higher education
Small businesses
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Public and State controlled institutions of higher education
State governments
County governments
Special district governments
Independent school districts
For profit organizations other than small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: This Notice of Funding Opportunity (NOFO) invites U54 Cooperative Agreement applications aiming to establish multi-component Alzheimers Disease and Related Dementias Translational Centers for Microphysiological Systems (MPS) (AD/ADRD MPS Translational Centers). The overarching purpose of this Centers program is to develop 2D and 3D models of AD/ADRD as reproducible and scalable platforms that recapitulate key features of human AD/ADRD pathophysiology to be used as precision medicine research tools to investigate the complex biology of AD/ADRD and to accelerate multiple aspects of drug discovery and preclinical drug development.
Link to Additional Information: https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-24-040.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Folder 350629 Full Announcement-RFA-AG-24-040 -> RFA-AG-24-040-Full-Announcement.pdf

Packages

Agency Contact Information: NIH Grants Information
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-H Use for due dates on or after January 25, 2023 PKG00283549 Jan 15, 2024 Feb 15, 2024 View

Package 1

Mandatory forms

350629 RR_SF424_5_0-5.0.pdf

350629 PHS398_CoverPageSupplement_5_0-5.0.pdf

350629 RR_OtherProjectInfo_1_4-1.4.pdf

350629 PerformanceSite_4_0-4.0.pdf

350629 RR_KeyPersonExpanded_4_0-4.0.pdf

350629 PHS398_ResearchPlan_5_0-5.0.pdf

350629 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

350629 PHS_Additional_IndirectCosts_2_0-2.0.pdf

350629 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-11T12:54:33-05:00

Share This Post, Choose Your Platform!

About the Author: